Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study

Hepatology

Volumn 63, Issue 3, 2016, Pages 827-838

  Piscaglia, Fabio ^a   Svegliati Baroni, Gianluca ^b   Barchetti, Andrea ^c   Pecorelli, Anna ^a   Marinelli, Sara ^a   Tiribelli, Claudio ^c,d   Bellentani, Stefano ^c   Bernardi, Mauro ^e   Biselli, Maurizio ^e   Caraceni, Paolo ^e   Domenicali, Marco ^e   Garuti, Francesca ^e   Gramenzi, Annagiulia ^e   Lenzi, Barbara ^e   Magalotti, Donatella ^e   Cescon, Matteo ^e   Ravaioli, Matteo ^e   Del Poggio, Paolo ^f   Olmi, Stefano ^f   Rapaccini, Gian Ludovico ^g   Balsamo, Claudia ^h   Di Nolfo, Maria Anna ^h   Vavassori, Elena ^h   Alberti, Alfredo ⁱ   Benvegnàu, Luisa ⁱ   Gatta, Angelo ⁱ   Giacomin, Anna ⁱ   Vanin, Veronica ⁱ   Pozzan, Caterina ⁱ   Maddalo, Gemma ⁱ   Giampalma, Emanuela ^a   Cappelli, Alberta ^a   Golfieri, Rita ^a   Mosconi, Cristina ^a   Renzulli, Matteo ^a   Roselli, Paola ^j   Dell’isola, Serena ^j   Ialungo, Anna Maria ^j   Risso, Domenico ^k   Marenco, Simona ^k   Sammito, Giorgio ^k   Bruzzone, Linda ^k   Bosco, Giulia ^g   Grieco, Antonio ^g   Pompili, Maurizio ^g   Rinninella, Emanuele ^g   Siciliano, Massimo ^g   Chiaramonte, Maria ^l   Guarino, Maria ^m   Cammà, Calogero ⁿ   Maida, Marcello ⁿ   Costantino, Andrea ⁿ   Barcellona, Maria Rosa ⁿ   Schiadà, Laura ^b   Gemini, Stefano ^b   Lanzi, Arianna ^o   Stefanini, Giuseppe Francesco ^o   Dall’aglio, Anna Chiara ^o   Cappa, Federica Mirici ^o   Suzzi, Alessandra ^o   Mussetto, Alessandro ^o   Treossi, Omero ^o   Missale, Gabriele ^p   Porro, Emanuela ^p   Mismas, Valeria ^q   Vivaldi, Caterina ^q   Bolondi, Luigi ^a   Zoli, Marco ^a   Granito, Alessandro ^a   Malagotti, Daniela ^a   Tovoli, Francesco ^a   Trevisani, Franco ^a   Venerandi, Laura ^a   Brandi, Giovanni ^a   Cucchetti, Alessandro ^a   Bugianesi, Elisabetta ^r   Vanni, Ester ^r   Mezzabotta, Lavinia ^r   Cabibbo, Giuseppe ⁿ   Petta, Salvo ⁿ   Fracanzani, Anna ^s   Fargion, Silvia ^s   Marra, Fabio ^t   Fani, Bernardo ^t   Biasini, Elisabetta ^p   Sacco, Rodolfo ^q   Morisco, Filomena ^m   Caporaso, Nicola ^m   Colombo, Massimo ^u   D’ambrosio, Roberta ^u   Crocè, Lory S ^c   Patti, Riccardo ^c   Giannini, Edoardo G ^v   Loria, Paola ^w   Lonardo, Amedeo ^w   Baldelli, Enrica ^w   Miele, Luca ^g   Farinati, Fabio ⁱ   Borzio, Mauro ^x   Dionigi, Elena ^x   Soardo, Giorgio ^y   Caturelli, Eugenio ^j   Ciccarese, Francesca ^z   Virdone, Roberto ^aa   Affronti, Andrea ^aa   Foschi, Francesco Giuseppe ^ab   Borzio, Franco ^ac   more..

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c Centro Studi Fegato   (Italy)

^d UNIVERSITY OF TRIESTE   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f UnitàOperativadiChirurgia PoliclinicoS Marco   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h BOLOGNINI HOSPITAL   (Italy)

ⁱ UNIVERSITY OF PADOVA   (Italy)

^j BELCOLLE HOSPITAL   (Italy)

^k UNIVERSITY OF GENOA   (Italy)

^l SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^m UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁿ UNIVERSITY OF PALERMO   (Italy)

^o Ospedale per gli Infermi di Faenza   (Italy)

^p UNIVERSITY HOSPITAL OF PARMA   (Italy)

^q UNIVERSITY HOSPITAL OF PISA   (Italy)

^r UNIVERSITY OF TURIN   (Italy)

^s FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^t UNIVERSITY OF FLORENCE   (Italy)

^u UNIVERSITY OF MILAN   (Italy)

^v UNIVERSITY OF GENOA   (Italy)

^w UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^x Azienda Ospedaliera di Melegnano   (Italy)

^y Ospedale di Udine   (Italy)

^z Divisione di Chirurgia   (Italy)

^aa VILLA SOFIA CERVELLO HOSPITAL   (Italy)

^ab Dipartimento di Medicina Interna   (Italy)

^ac FATEBENEFRATELLI HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHRONIC LIVER DISEASE; CLINICAL FEATURE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONALCOHOLIC FATTY LIVER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SECONDARY HEALTH CARE; CHRONIC HEPATITIS C; CLINICAL TRIAL; COMPLICATION; LIVER TUMOR; MIDDLE AGED; MORTALITY; VERY ELDERLY; VIROLOGY;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PROSPECTIVE STUDIES;

EID: 84954288767     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28368     Document Type: Article

References (27)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. El-Serag HB, Kanwal F. Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go? Hepatology 2014;60:1767-1775.
3. Cazzagon N, Trevisani F, Maddalo G, Giacomin A, Vanin V, Pozzan C, et al. Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres. Liver Int 2013;33:1420-1427.
4. Kim DY, Han KH. Epidemiology and surveillance of hepatocellular carcinoma. Liver Cancer 2012;1:2-14.
5. De Minicis S, Day C, Svegliati-Baroni G. From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights. Curr Pharm Des 2013;19:5239-5249.
6. Nascimbeni F, Pais R, Bellentani S, Day CP, Ratziu V, Loria P, et al. From NAFLD in clinical practice to answers from guidelines. J Hepatol 2013;59:859-871.
7. Lonardo A, Bellentani S, Ratziu V, Loria P. Insulin resistance in nonalcoholic steatohepatitis: necessary but not sufficient-death of a dogma from analysis of therapeutic studies? Expert Rev Gastroenterol Hepatol 2011;5:279-289.
8. Marchesini G, Forlani G. NASH: from liver diseases to metabolic disorders and back to clinical hepatology. Hepatology 2002;35:497-499.
9. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005;54:533-539.
10. Rosmorduc O, Fartoux L. HCC and NASH: how strong is the clinical demonstration? Clin Res Hepatol Gastroenterol 2012;36:202-208.
11. Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 2014;384:755-765.
12. Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 2013;56:1384-1391.
13. Cucchetti A, Trevisani F, Pecorelli A, Erroi V, Farinati F, Ciccarese F, et al. Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma. J Hepatol 2014;61:333-341.
14. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-943.
15. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.
16. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012;55:2005-2023.
17. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-1321.
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
19. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
20. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526.
21. Jang ES, Yoon JH, Chung JW, Cho EJ, Yu SJ, Lee JH, et al. Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization. J Cancer Res Clin Oncol 2013;139:635-643.
22. Kneuertz PJ, Demirjian A, Firoozmand A, Corona-Villalobos C, Bhagat N, Herman J, et al. Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes. Ann Surg Oncol 2012;19:2897-2907.
23. Italian Association for the Study of the Liver. Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma. Dig Liver Dis 2013;45:712-723.
24. Paradis V, Zalinski S, Chelbi E, Guedj N, Degos F, Vilgrain V, et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 2009;49:851-859.
25. Reddy SK, Steel JL, Chen HW, DeMateo DJ, Cardinal J, Behari J, et al. Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease. Hepatology 2012;55:1809-1819.
26. Yasui K, Hashimoto E, Komorizono Y, Koike K, Arii S, Imai Y, et al. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol 2011;9:428-433; e450.
27. Shield KD, Rylett M, Gmel G, Kehoe-Chan TA, Rehm J. Global alcohol exposure estimates by country, territory and region for 2005-a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study. Addiction 2013;108:912-922.